nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.144	0.208	CbGbCtD
Fosphenytoin—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.1	0.145	CbGbCtD
Fosphenytoin—CYP2C8—Progesterone—uterine cancer	0.0952	0.137	CbGbCtD
Fosphenytoin—CYP2C19—Progesterone—uterine cancer	0.0798	0.115	CbGbCtD
Fosphenytoin—CYP2C9—Progesterone—uterine cancer	0.0664	0.0959	CbGbCtD
Fosphenytoin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0583	0.0842	CbGbCtD
Fosphenytoin—CYP2C8—Etoposide—uterine cancer	0.0426	0.0615	CbGbCtD
Fosphenytoin—CYP3A4—Progesterone—uterine cancer	0.0386	0.0558	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—uterine cancer	0.0383	0.0554	CbGbCtD
Fosphenytoin—CYP3A4—Etoposide—uterine cancer	0.0173	0.025	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—uterine cancer	0.0118	0.017	CbGbCtD
Fosphenytoin—Lymphadenopathy—Epirubicin—uterine cancer	0.000339	0.0011	CcSEcCtD
Fosphenytoin—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000339	0.0011	CcSEcCtD
Fosphenytoin—Coma—Doxorubicin—uterine cancer	0.000337	0.0011	CcSEcCtD
Fosphenytoin—Rash maculo-papular—Doxorubicin—uterine cancer	0.000336	0.00109	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Epirubicin—uterine cancer	0.000335	0.00109	CcSEcCtD
Fosphenytoin—Anorexia—Dactinomycin—uterine cancer	0.000334	0.00109	CcSEcCtD
Fosphenytoin—Ecchymosis—Doxorubicin—uterine cancer	0.000334	0.00108	CcSEcCtD
Fosphenytoin—Dizziness—Progesterone—uterine cancer	0.000328	0.00107	CcSEcCtD
Fosphenytoin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000323	0.00105	CcSEcCtD
Fosphenytoin—Eye pain—Epirubicin—uterine cancer	0.000321	0.00104	CcSEcCtD
Fosphenytoin—Chills—Etoposide—uterine cancer	0.000321	0.00104	CcSEcCtD
Fosphenytoin—Mental disability—Doxorubicin—uterine cancer	0.00032	0.00104	CcSEcCtD
Fosphenytoin—Sepsis—Doxorubicin—uterine cancer	0.00032	0.00104	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00032	0.00104	CcSEcCtD
Fosphenytoin—Cardiac failure congestive—Epirubicin—uterine cancer	0.000319	0.00104	CcSEcCtD
Fosphenytoin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000318	0.00103	CcSEcCtD
Fosphenytoin—Vomiting—Progesterone—uterine cancer	0.000316	0.00102	CcSEcCtD
Fosphenytoin—Lymphadenopathy—Doxorubicin—uterine cancer	0.000314	0.00102	CcSEcCtD
Fosphenytoin—Rash—Progesterone—uterine cancer	0.000313	0.00102	CcSEcCtD
Fosphenytoin—Dermatitis—Progesterone—uterine cancer	0.000313	0.00102	CcSEcCtD
Fosphenytoin—Headache—Progesterone—uterine cancer	0.000311	0.00101	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Doxorubicin—uterine cancer	0.00031	0.00101	CcSEcCtD
Fosphenytoin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000308	0.000999	CcSEcCtD
Fosphenytoin—Decreased appetite—Dactinomycin—uterine cancer	0.000305	0.00099	CcSEcCtD
Fosphenytoin—Dysgeusia—Etoposide—uterine cancer	0.000305	0.000989	CcSEcCtD
Fosphenytoin—Back pain—Etoposide—uterine cancer	0.000301	0.000977	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000299	0.000972	CcSEcCtD
Fosphenytoin—Muscle spasms—Etoposide—uterine cancer	0.000299	0.000971	CcSEcCtD
Fosphenytoin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000297	0.000966	CcSEcCtD
Fosphenytoin—Eye pain—Doxorubicin—uterine cancer	0.000297	0.000964	CcSEcCtD
Fosphenytoin—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000295	0.000959	CcSEcCtD
Fosphenytoin—Nausea—Progesterone—uterine cancer	0.000295	0.000957	CcSEcCtD
Fosphenytoin—Osteoarthritis—Epirubicin—uterine cancer	0.00029	0.00094	CcSEcCtD
Fosphenytoin—Diplopia—Epirubicin—uterine cancer	0.00029	0.00094	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.00029	0.00094	CcSEcCtD
Fosphenytoin—Feeling abnormal—Dactinomycin—uterine cancer	0.000289	0.000939	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Etoposide—uterine cancer	0.000289	0.000937	CcSEcCtD
Fosphenytoin—Anaemia—Etoposide—uterine cancer	0.000288	0.000934	CcSEcCtD
Fosphenytoin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000286	0.000929	CcSEcCtD
Fosphenytoin—Migraine—Epirubicin—uterine cancer	0.000285	0.000926	CcSEcCtD
Fosphenytoin—Affect lability—Epirubicin—uterine cancer	0.000285	0.000926	CcSEcCtD
Fosphenytoin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000284	0.000921	CcSEcCtD
Fosphenytoin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000283	0.00092	CcSEcCtD
Fosphenytoin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000282	0.000915	CcSEcCtD
Fosphenytoin—Malaise—Etoposide—uterine cancer	0.000281	0.000911	CcSEcCtD
Fosphenytoin—Face oedema—Epirubicin—uterine cancer	0.00028	0.000908	CcSEcCtD
Fosphenytoin—Vertigo—Etoposide—uterine cancer	0.00028	0.000908	CcSEcCtD
Fosphenytoin—Leukopenia—Etoposide—uterine cancer	0.000278	0.000904	CcSEcCtD
Fosphenytoin—Body temperature increased—Dactinomycin—uterine cancer	0.000277	0.000901	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000277	0.000899	CcSEcCtD
Fosphenytoin—Cardiac arrest—Epirubicin—uterine cancer	0.000275	0.000894	CcSEcCtD
Fosphenytoin—Mood swings—Epirubicin—uterine cancer	0.000274	0.000891	CcSEcCtD
Fosphenytoin—Loss of consciousness—Etoposide—uterine cancer	0.000273	0.000888	CcSEcCtD
Fosphenytoin—Ataxia—Epirubicin—uterine cancer	0.000272	0.000884	CcSEcCtD
Fosphenytoin—Cough—Etoposide—uterine cancer	0.000271	0.000882	CcSEcCtD
Fosphenytoin—Convulsion—Etoposide—uterine cancer	0.00027	0.000875	CcSEcCtD
Fosphenytoin—Dehydration—Epirubicin—uterine cancer	0.000269	0.000875	CcSEcCtD
Fosphenytoin—Hypertension—Etoposide—uterine cancer	0.000269	0.000872	CcSEcCtD
Fosphenytoin—Diplopia—Doxorubicin—uterine cancer	0.000268	0.00087	CcSEcCtD
Fosphenytoin—Osteoarthritis—Doxorubicin—uterine cancer	0.000268	0.00087	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000268	0.00087	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Epirubicin—uterine cancer	0.000267	0.000868	CcSEcCtD
Fosphenytoin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000267	0.000868	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Epirubicin—uterine cancer	0.000264	0.000859	CcSEcCtD
Fosphenytoin—Migraine—Doxorubicin—uterine cancer	0.000264	0.000856	CcSEcCtD
Fosphenytoin—Affect lability—Doxorubicin—uterine cancer	0.000264	0.000856	CcSEcCtD
Fosphenytoin—Hypokalaemia—Epirubicin—uterine cancer	0.000264	0.000856	CcSEcCtD
Fosphenytoin—Discomfort—Etoposide—uterine cancer	0.000262	0.00085	CcSEcCtD
Fosphenytoin—Face oedema—Doxorubicin—uterine cancer	0.000259	0.00084	CcSEcCtD
Fosphenytoin—Gastritis—Epirubicin—uterine cancer	0.000256	0.000832	CcSEcCtD
Fosphenytoin—Confusional state—Etoposide—uterine cancer	0.000256	0.000831	CcSEcCtD
Fosphenytoin—Muscular weakness—Epirubicin—uterine cancer	0.000255	0.000829	CcSEcCtD
Fosphenytoin—Cardiac arrest—Doxorubicin—uterine cancer	0.000255	0.000827	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Etoposide—uterine cancer	0.000254	0.000825	CcSEcCtD
Fosphenytoin—Mood swings—Doxorubicin—uterine cancer	0.000254	0.000824	CcSEcCtD
Fosphenytoin—Infection—Etoposide—uterine cancer	0.000252	0.000819	CcSEcCtD
Fosphenytoin—Ataxia—Doxorubicin—uterine cancer	0.000252	0.000818	CcSEcCtD
Fosphenytoin—Asthenia—Dactinomycin—uterine cancer	0.000252	0.000817	CcSEcCtD
Fosphenytoin—Dysphagia—Epirubicin—uterine cancer	0.00025	0.000813	CcSEcCtD
Fosphenytoin—Influenza—Epirubicin—uterine cancer	0.00025	0.000813	CcSEcCtD
Fosphenytoin—Asthma—Epirubicin—uterine cancer	0.00025	0.000813	CcSEcCtD
Fosphenytoin—Dehydration—Doxorubicin—uterine cancer	0.000249	0.000809	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Etoposide—uterine cancer	0.000249	0.000807	CcSEcCtD
Fosphenytoin—Tachycardia—Etoposide—uterine cancer	0.000248	0.000805	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Doxorubicin—uterine cancer	0.000247	0.000803	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Etoposide—uterine cancer	0.000245	0.000797	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000245	0.000795	CcSEcCtD
Fosphenytoin—Hypokalaemia—Doxorubicin—uterine cancer	0.000244	0.000792	CcSEcCtD
Fosphenytoin—Anorexia—Etoposide—uterine cancer	0.000242	0.000786	CcSEcCtD
Fosphenytoin—Bronchitis—Epirubicin—uterine cancer	0.000241	0.000782	CcSEcCtD
Fosphenytoin—Diarrhoea—Dactinomycin—uterine cancer	0.00024	0.000779	CcSEcCtD
Fosphenytoin—Hypotension—Etoposide—uterine cancer	0.000237	0.00077	CcSEcCtD
Fosphenytoin—Gastritis—Doxorubicin—uterine cancer	0.000237	0.00077	CcSEcCtD
Fosphenytoin—Muscular weakness—Doxorubicin—uterine cancer	0.000236	0.000767	CcSEcCtD
Fosphenytoin—Dysuria—Epirubicin—uterine cancer	0.000234	0.00076	CcSEcCtD
Fosphenytoin—Asthma—Doxorubicin—uterine cancer	0.000232	0.000752	CcSEcCtD
Fosphenytoin—Dysphagia—Doxorubicin—uterine cancer	0.000232	0.000752	CcSEcCtD
Fosphenytoin—Influenza—Doxorubicin—uterine cancer	0.000232	0.000752	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Epirubicin—uterine cancer	0.000228	0.000742	CcSEcCtD
Fosphenytoin—Paraesthesia—Etoposide—uterine cancer	0.000228	0.00074	CcSEcCtD
Fosphenytoin—Dyspnoea—Etoposide—uterine cancer	0.000226	0.000735	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Epirubicin—uterine cancer	0.000226	0.000733	CcSEcCtD
Fosphenytoin—Somnolence—Etoposide—uterine cancer	0.000226	0.000733	CcSEcCtD
Fosphenytoin—Pneumonia—Epirubicin—uterine cancer	0.000224	0.000729	CcSEcCtD
Fosphenytoin—Vomiting—Dactinomycin—uterine cancer	0.000223	0.000724	CcSEcCtD
Fosphenytoin—Bronchitis—Doxorubicin—uterine cancer	0.000223	0.000723	CcSEcCtD
Fosphenytoin—Rash—Dactinomycin—uterine cancer	0.000221	0.000718	CcSEcCtD
Fosphenytoin—Decreased appetite—Etoposide—uterine cancer	0.000221	0.000717	CcSEcCtD
Fosphenytoin—Renal failure—Epirubicin—uterine cancer	0.000219	0.000712	CcSEcCtD
Fosphenytoin—Constipation—Etoposide—uterine cancer	0.000217	0.000705	CcSEcCtD
Fosphenytoin—Conjunctivitis—Epirubicin—uterine cancer	0.000217	0.000704	CcSEcCtD
Fosphenytoin—Dysuria—Doxorubicin—uterine cancer	0.000217	0.000703	CcSEcCtD
Fosphenytoin—Sweating—Epirubicin—uterine cancer	0.000214	0.000695	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000211	0.000686	CcSEcCtD
Fosphenytoin—Epistaxis—Epirubicin—uterine cancer	0.00021	0.000684	CcSEcCtD
Fosphenytoin—Sinusitis—Epirubicin—uterine cancer	0.000209	0.00068	CcSEcCtD
Fosphenytoin—Feeling abnormal—Etoposide—uterine cancer	0.000209	0.000679	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Doxorubicin—uterine cancer	0.000209	0.000678	CcSEcCtD
Fosphenytoin—Nausea—Dactinomycin—uterine cancer	0.000208	0.000677	CcSEcCtD
Fosphenytoin—Pneumonia—Doxorubicin—uterine cancer	0.000208	0.000674	CcSEcCtD
Fosphenytoin—Bradycardia—Epirubicin—uterine cancer	0.000204	0.000662	CcSEcCtD
Fosphenytoin—Renal failure—Doxorubicin—uterine cancer	0.000203	0.000659	CcSEcCtD
Fosphenytoin—Urticaria—Etoposide—uterine cancer	0.000202	0.000655	CcSEcCtD
Fosphenytoin—Rhinitis—Epirubicin—uterine cancer	0.000201	0.000652	CcSEcCtD
Fosphenytoin—Body temperature increased—Etoposide—uterine cancer	0.000201	0.000652	CcSEcCtD
Fosphenytoin—Conjunctivitis—Doxorubicin—uterine cancer	0.000201	0.000652	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Epirubicin—uterine cancer	0.000199	0.000647	CcSEcCtD
Fosphenytoin—Pharyngitis—Epirubicin—uterine cancer	0.000199	0.000646	CcSEcCtD
Fosphenytoin—Sweating—Doxorubicin—uterine cancer	0.000198	0.000643	CcSEcCtD
Fosphenytoin—Epistaxis—Doxorubicin—uterine cancer	0.000195	0.000632	CcSEcCtD
Fosphenytoin—Sinusitis—Doxorubicin—uterine cancer	0.000194	0.000629	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—uterine cancer	0.000189	0.000613	CcSEcCtD
Fosphenytoin—Tinnitus—Epirubicin—uterine cancer	0.000187	0.000607	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—uterine cancer	0.000186	0.000603	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—uterine cancer	0.000184	0.000599	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—uterine cancer	0.000184	0.000597	CcSEcCtD
Fosphenytoin—Asthenia—Etoposide—uterine cancer	0.000182	0.000592	CcSEcCtD
Fosphenytoin—Chills—Epirubicin—uterine cancer	0.00018	0.000584	CcSEcCtD
Fosphenytoin—Pruritus—Etoposide—uterine cancer	0.00018	0.000583	CcSEcCtD
Fosphenytoin—Diarrhoea—Etoposide—uterine cancer	0.000174	0.000564	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—uterine cancer	0.000173	0.000561	CcSEcCtD
Fosphenytoin—Flatulence—Epirubicin—uterine cancer	0.000172	0.000558	CcSEcCtD
Fosphenytoin—Tension—Epirubicin—uterine cancer	0.000171	0.000556	CcSEcCtD
Fosphenytoin—Dysgeusia—Epirubicin—uterine cancer	0.000171	0.000555	CcSEcCtD
Fosphenytoin—Nervousness—Epirubicin—uterine cancer	0.000169	0.00055	CcSEcCtD
Fosphenytoin—Back pain—Epirubicin—uterine cancer	0.000169	0.000548	CcSEcCtD
Fosphenytoin—Dizziness—Etoposide—uterine cancer	0.000168	0.000545	CcSEcCtD
Fosphenytoin—Muscle spasms—Epirubicin—uterine cancer	0.000168	0.000544	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—uterine cancer	0.000166	0.00054	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Epirubicin—uterine cancer	0.000162	0.000525	CcSEcCtD
Fosphenytoin—Vomiting—Etoposide—uterine cancer	0.000161	0.000524	CcSEcCtD
Fosphenytoin—Anaemia—Epirubicin—uterine cancer	0.000161	0.000523	CcSEcCtD
Fosphenytoin—Agitation—Epirubicin—uterine cancer	0.00016	0.00052	CcSEcCtD
Fosphenytoin—Rash—Etoposide—uterine cancer	0.00016	0.00052	CcSEcCtD
Fosphenytoin—Dermatitis—Etoposide—uterine cancer	0.00016	0.000519	CcSEcCtD
Fosphenytoin—Headache—Etoposide—uterine cancer	0.000159	0.000517	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—uterine cancer	0.000159	0.000516	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—uterine cancer	0.000158	0.000514	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—uterine cancer	0.000158	0.000513	CcSEcCtD
Fosphenytoin—Malaise—Epirubicin—uterine cancer	0.000157	0.000511	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—uterine cancer	0.000157	0.000509	CcSEcCtD
Fosphenytoin—Vertigo—Epirubicin—uterine cancer	0.000157	0.000509	CcSEcCtD
Fosphenytoin—Syncope—Epirubicin—uterine cancer	0.000156	0.000508	CcSEcCtD
Fosphenytoin—Leukopenia—Epirubicin—uterine cancer	0.000156	0.000507	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—uterine cancer	0.000156	0.000507	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—uterine cancer	0.000155	0.000504	CcSEcCtD
Fosphenytoin—Palpitations—Epirubicin—uterine cancer	0.000154	0.0005	CcSEcCtD
Fosphenytoin—Loss of consciousness—Epirubicin—uterine cancer	0.000153	0.000498	CcSEcCtD
Fosphenytoin—Cough—Epirubicin—uterine cancer	0.000152	0.000494	CcSEcCtD
Fosphenytoin—Convulsion—Epirubicin—uterine cancer	0.000151	0.000491	CcSEcCtD
Fosphenytoin—Nausea—Etoposide—uterine cancer	0.000151	0.00049	CcSEcCtD
Fosphenytoin—Hypertension—Epirubicin—uterine cancer	0.000151	0.000489	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—uterine cancer	0.00015	0.000486	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—uterine cancer	0.000149	0.000484	CcSEcCtD
Fosphenytoin—Myalgia—Epirubicin—uterine cancer	0.000148	0.000482	CcSEcCtD
Fosphenytoin—Arthralgia—Epirubicin—uterine cancer	0.000148	0.000482	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—uterine cancer	0.000148	0.000482	CcSEcCtD
Fosphenytoin—Discomfort—Epirubicin—uterine cancer	0.000147	0.000476	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—uterine cancer	0.000146	0.000473	CcSEcCtD
Fosphenytoin—Dry mouth—Epirubicin—uterine cancer	0.000145	0.000472	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—uterine cancer	0.000145	0.000471	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—uterine cancer	0.000145	0.00047	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—uterine cancer	0.000144	0.000469	CcSEcCtD
Fosphenytoin—Confusional state—Epirubicin—uterine cancer	0.000144	0.000466	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—uterine cancer	0.000143	0.000463	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Epirubicin—uterine cancer	0.000142	0.000462	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—uterine cancer	0.000142	0.000461	CcSEcCtD
Fosphenytoin—Infection—Epirubicin—uterine cancer	0.000141	0.000459	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—uterine cancer	0.000141	0.000457	CcSEcCtD
Fosphenytoin—Shock—Epirubicin—uterine cancer	0.00014	0.000455	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—uterine cancer	0.00014	0.000454	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Epirubicin—uterine cancer	0.000139	0.000453	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—uterine cancer	0.000139	0.000452	CcSEcCtD
Fosphenytoin—Tachycardia—Epirubicin—uterine cancer	0.000139	0.000451	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Epirubicin—uterine cancer	0.000138	0.000447	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—uterine cancer	0.000137	0.000446	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—uterine cancer	0.000137	0.000446	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—uterine cancer	0.000136	0.000441	CcSEcCtD
Fosphenytoin—Anorexia—Epirubicin—uterine cancer	0.000136	0.000441	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—uterine cancer	0.000134	0.000436	CcSEcCtD
Fosphenytoin—Hypotension—Epirubicin—uterine cancer	0.000133	0.000432	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—uterine cancer	0.000133	0.000431	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000132	0.000428	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—uterine cancer	0.000131	0.000425	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00013	0.000421	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—uterine cancer	0.00013	0.000421	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000129	0.000419	CcSEcCtD
Fosphenytoin—Insomnia—Epirubicin—uterine cancer	0.000129	0.000418	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—uterine cancer	0.000129	0.000417	CcSEcCtD
Fosphenytoin—Paraesthesia—Epirubicin—uterine cancer	0.000128	0.000415	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000127	0.000413	CcSEcCtD
Fosphenytoin—Dyspnoea—Epirubicin—uterine cancer	0.000127	0.000412	CcSEcCtD
Fosphenytoin—Somnolence—Epirubicin—uterine cancer	0.000127	0.000411	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—uterine cancer	0.000126	0.000408	CcSEcCtD
Fosphenytoin—Dyspepsia—Epirubicin—uterine cancer	0.000125	0.000407	CcSEcCtD
Fosphenytoin—Decreased appetite—Epirubicin—uterine cancer	0.000124	0.000402	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—uterine cancer	0.000123	0.0004	CcSEcCtD
Fosphenytoin—Constipation—Epirubicin—uterine cancer	0.000122	0.000395	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00012	0.00039	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—uterine cancer	0.000119	0.000387	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—uterine cancer	0.000118	0.000384	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—uterine cancer	0.000117	0.000381	CcSEcCtD
Fosphenytoin—Feeling abnormal—Epirubicin—uterine cancer	0.000117	0.000381	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—uterine cancer	0.000117	0.00038	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—uterine cancer	0.000116	0.000376	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—uterine cancer	0.000114	0.000372	CcSEcCtD
Fosphenytoin—Urticaria—Epirubicin—uterine cancer	0.000113	0.000367	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—uterine cancer	0.000113	0.000366	CcSEcCtD
Fosphenytoin—Body temperature increased—Epirubicin—uterine cancer	0.000113	0.000365	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—uterine cancer	0.000109	0.000352	CcSEcCtD
Fosphenytoin—Urticaria—Doxorubicin—uterine cancer	0.000105	0.00034	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—uterine cancer	0.000104	0.000338	CcSEcCtD
Fosphenytoin—Asthenia—Epirubicin—uterine cancer	0.000102	0.000332	CcSEcCtD
Fosphenytoin—Pruritus—Epirubicin—uterine cancer	0.000101	0.000327	CcSEcCtD
Fosphenytoin—Diarrhoea—Epirubicin—uterine cancer	9.74e-05	0.000316	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—uterine cancer	9.45e-05	0.000307	CcSEcCtD
Fosphenytoin—Dizziness—Epirubicin—uterine cancer	9.41e-05	0.000306	CcSEcCtD
Fosphenytoin—Pruritus—Doxorubicin—uterine cancer	9.32e-05	0.000303	CcSEcCtD
Fosphenytoin—Vomiting—Epirubicin—uterine cancer	9.05e-05	0.000294	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—uterine cancer	9.01e-05	0.000293	CcSEcCtD
Fosphenytoin—Rash—Epirubicin—uterine cancer	8.97e-05	0.000291	CcSEcCtD
Fosphenytoin—Dermatitis—Epirubicin—uterine cancer	8.97e-05	0.000291	CcSEcCtD
Fosphenytoin—Headache—Epirubicin—uterine cancer	8.92e-05	0.00029	CcSEcCtD
Fosphenytoin—Dizziness—Doxorubicin—uterine cancer	8.71e-05	0.000283	CcSEcCtD
Fosphenytoin—Nausea—Epirubicin—uterine cancer	8.45e-05	0.000275	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—uterine cancer	8.37e-05	0.000272	CcSEcCtD
Fosphenytoin—Rash—Doxorubicin—uterine cancer	8.3e-05	0.00027	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—uterine cancer	8.3e-05	0.000269	CcSEcCtD
Fosphenytoin—Headache—Doxorubicin—uterine cancer	8.25e-05	0.000268	CcSEcCtD
Fosphenytoin—Nausea—Doxorubicin—uterine cancer	7.82e-05	0.000254	CcSEcCtD
